SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Ondas, Inc. engages in the development, marketing, and sale of wireless radio systems for secure, wide area mission-critical business-to-business networks. It operates through the Ondas Networks and Ondas Autonomous Systems segments. The Ondas Networks segment provides wireless connectivity solutions enabling mission-critical Industrial Internet applications and services. The Ondas Autonomous Systems segment designs, develops, and markets commercial drone solutions via the Optimus System and Scout System. The company was founded on December 22, 2014 and is headquartered in West Palm Beach, FL.

Ondas Inc.

Ondas Inc

Ondas (ONDS) is trending after announcing a strategic partnership with Palantir and World View to develop AI-enabled multi-domain intelligence and defense platforms. The community is buzzing with excitement over this collaboration, anticipating a significant short squeeze and viewing it as a transformative catalyst for future growth in the autonomous systems sector.

Rivian Automotive, Inc. engages in the design, development, and manufacture of category-defining electric vehicles and accessories. It operates through following segments: Automotive, Software and Services. The company was founded by Robert J. Scaringe in June 2009 and is headquartered in Irvine, CA.

Rivian Automotive Inc - Ordinary Shares - Class A

Rivian Automotive Inc

Rivian is actively trending as investors weigh the upcoming R2 reveal against leaked pricing details, with the community split between bullish excitement over potential market share and bearish concerns regarding the long-term path to profitability. The conversation is dominated by debates over whether the new vehicle lineup's pricing and delivery timelines can effectively challenge established EV competitors in a volatile market environment.

CitroTech, Inc. is an integrated environmental service company, which engages in the provision of field services, remediation transportation, and EHS compliance services. It also offers on-site technical services, on-site and off-site treatment for hazardous and non-hazardous waste. The company was founded on March 14, 1990 and is headquartered in Cheyenne, WY.

CitroTech Inc.

CitroTech Inc. is trending as momentum traders crowd the stock following a bullish breakout fueled by investor conference exposure and a clear, growth-oriented wildfire prevention narrative. The community is focused on the company's unique regulatory moat, characterized by EPA Safer Choice certification for its non-toxic fire-inhibitor technology, which has sparked speculation about institutional interest and further upside potential.

GameStop Corp. engages in offering games and entertainment products through its ecommerce properties and stores. The firm’s stores and ecommerce sites operate primarily under the names GameStop, EB Games, and Micromania. It operates through the following geographical segments: United States, Canada, Australia, and Europe. The company was founded by Daniel A. DeMatteo in 1996 and is headquartered in Grapevine, TX.

Gamestop Corporation - Ordinary Shares - Class A

GameStop Corp

GameStop is trending as investors digest persistent price compression and speculative chatter regarding a potential acquisition or M&A announcement. The community remains deeply divided, with some betting on a long-awaited short squeeze driven by technical setups, while others voice frustration over stagnant price action and the lack of recent leadership communication.

QXO, Inc. is a publicly traded distributor of roofing, waterproofing and complementary building products in the United States. It plans to become tech-enabled in the building products distribution industry and generate outsized value for shareholders. The company was founded on October 3, 2002, and is headquartered in Greenwich, CT.

QXO Inc.

QXO is trending as investors digest news of a $2.25 billion acquisition of Kodiak Building Partners, with the community expressing optimism about the company's aggressive M&A strategy and potential for long-term growth. While some participants discuss short-term volatility and liquidity, the broader sentiment remains heavily focused on the leadership's execution track record and the expectation of future deal announcements.

Rubrik, Inc. engages in the provision of cloud data management solutions. Its solutions include backup and recovery, VM backup, Microsoft 365, ransom ware recovery, database backup, cloud solutions, and Polaris sonar. Rubrik products include data protection, data threat analytics, data security posture and cyber recovery. The company was founded by Bipul Sinha, Arvind Jain, Soham Mazumdar, and Arvind Nithrakashyap in December 2013 and is headquartered in Palo Alto, CA.

Rubrik Inc. - Ordinary Shares - Class A

Rubrik Inc. - Class A

Rubrik is trending as investors weigh its strong AI-driven cyber resilience narrative and potential for long-term growth against recent volatility that has hit the broader software and cybersecurity sectors. While the community remains divided over short-term price pressure and insider selling, many are actively discussing the stock as a prime candidate for a rebound, emphasizing that its fundamental role in data protection makes it a critical infrastructure play for the AI era.

Himax Technologies, Inc. is a semiconductor solution provider dedicated to display imaging processing technologies. It operates through the Driver Integrated Circuit and Non-Driver Products segments. The company's products include display drivers, timing controllers, wafer level optics, video and display technology solutions, liquid crystal over silicon silicon, complementary metal-oxide semiconductor image sensor, and power integrated circuit. Its products used in TVs, laptops, monitors, mobile phones, tablets, digital cameras, car navigation, virtual reality (VR) devices and many other consumer electronics devices. Himax Technologies was founded by Biing Seng Wu and Jordan Wu on June 12, 2001 and is headquartered in Tainan, Taiwan.

Himax Technologies - ADR

Himax Technologies, Inc.

Himax Technologies is experiencing a surge in volume and price driven by growing investor confidence in its pivotal role as a supplier for Silicon Photonics and Co-Packaged Optics (CPO) solutions used in AI data centers. Community discussion is heavily focused on the company's technical partnerships and the potential for a long-term revenue inflection as these advanced optical components move toward commercial mass production.

Unusual Machines, Inc. is a development stage technology company, which engages in the provision of drone solutions with a focus on first-person view (FPV) technology. It offers products to entertainment, recreation, and competitive racing industries. The company was founded on July 11, 2019, and is headquartered in Orlando, FL.

Unusual Machines Inc

Unusual Machines is trending following strong financial results and its emphasized growth as a domestic drone component producer, with the community actively discussing its strategic "picks and shovels" role within the surging defense sector and the government's Drone Dominance Program.

Lightwave Logic, Inc. is a development stage company which engages in the commercialization of electro-optic photonic devices. The firm offers the P2ICTM technology platform which uses in-house proprietary organic polymers. Its products include electro-optical modulation devices and proprietary polymer photonic integrated circuits. The company was founded on June 24, 1997 and is headquartered in Englewood, CO.

Lightwave Logic Inc

Lightwave Logic is trending as investors react to a new development agreement with Tower Semiconductor, which integrates the company's high-speed polymer modulator technology into a commercial silicon photonics platform. The community is focused on the potential for this partnership to accelerate mass-market adoption among major AI and data center suppliers, leading to intense debate over the stock's long-term commercialization timeline versus its current high-volume speculative momentum.

Adobe, Inc. is a global technology company, which engages in the provision of digital marketing and media solutions. It operates through the following segments: Digital Media, Digital Experience, and Publishing and Advertising. The Digital Media segment offers products and services that enable individuals, teams, businesses, and enterprises to create, publish, and promote content anywhere and accelerate productivity by transforming view, share, engage with and collaborate on documents and creative content. The Digital Experience segment focuses on integrated platform and set of products, services, and solutions that enable businesses to create, manage, execute, measure, monetize, and optimize customer experiences that span from analytics to commerce. The Publishing and Advertising segment includes legacy products and services that address diverse market opportunities, including eLearning solutions, technical document publishing, web conferencing, document and forms platform, web app development, high-end printing, and Adobe Advertising offerings. The company was founded by Charles M. Geschke and John E. Warnock in December 1982 and is headquartered in San Jose, CA.

Adobe Inc

Adobe is facing intense downward pressure driven by market fears that generative AI will obsolete its core creative software and subscription model, leading to aggressive short-selling despite the company's strong free cash flow and recent analyst buy signals. Community sentiment remains deeply divided, with many investors currently fixated on poor price action and potential earnings volatility while bulls point to the stock's valuation as a generational entry point.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

$TTOO   Symposium Day 2 speaker 1:30pm  Dr. McCurdy’s  
 
Gemini said 
The 2025 report by Dr. Michael T. McCurdy and the Infection Management and Sepsis Collaborative Community (IMSCC) identifies a central paradox: we have &quot;Space Age&quot; technology like T2MR and FcMBL, but we are trying to prove they work using &quot;Stone Age&quot; benchmarks. 
 
Dr. McCurdy’s work highlights several specific hurdles that keep these life-saving DARPA-style innovations in the &quot;valley of death&quot; between the lab and the hospital bed. 
 
The Defense Advanced Research Projects Agency (DARPA) is essentially the &quot;mad scientist&quot; wing of the U.S. Department of Defense. 
 
 FDA and regulators still use blood cultures for comparison. 
 
The Hurdle: When a fast DARPA-funded test (like T2MR) finds a pathogen that a culture missed, regulators often view it as a &quot;false positive&quot; rather than a &quot;superior find.&quot; This makes it incredibly difficult to prove the diagnostic accuracy required for full clinical adoption.

Russell Martin

Ozark Entertainment

StockTwits Web

T2 Biosystems Inc

   Symposium Day 2 speaker 1:30pm  Dr. McCurdy’s  
 
Gemini said 
The 2025 report by Dr. Michael T. McCurdy and the Infection Management and Sepsis Collaborative Community (IMSCC) identifies a central paradox: we have "Space Age" technology like T2MR and FcMBL, but we are trying to prove they work using "Stone Age" benchmarks. 
 
Dr. McCurdy’s work highlights several specific hurdles that keep these life-saving DARPA-style innovations in the "valley of death" between the lab and the hospital bed. 
 
The Defense Advanced Research Projects Agency (DARPA) is essentially the "mad scientist" wing of the U.S. Department of Defense. 
 
 FDA and regulators still use blood cultures for comparison. 
 
The Hurdle: When a fast DARPA-funded test (like T2MR) finds a pathogen that a culture missed, regulators often view it as a "false positive" rather than a "superior find." This makes it incredibly difficult to prove the diagnostic accuracy required for full clinical adoption.

SeaStar Medical Holding Corp

Novice Trader

AI Info DD req&#39;d. 
Key Publications  Dr. McCurdy has authored over 100 peer-reviewed manuscripts. The following are the most relevant studies and papers regarding sepsis diagnostics and his work with Clairyon: 
 
Sepsis Alliance Collaborative Statement (2025): &quot;Challenges Facing Developers of Diagnostic Tests for Sepsis: A Report From Sepsis Alliance and the Infection Management and Sepsis Collaborative Community. 
&quot;Role: Michael T. McCurdy is the lead author. 
 
This paper evaluates the regulatory and clinical hurdles for diagnostic tests like T2MR, host-based assays, and other rapid pathogen identification tools.  
 
Diagnostic Sensitivity Study (2019): &quot;Blood Culture Results Before and After Antimicrobial Administration in Patients With Severe Manifestations of Sepsis: A Diagnostic Study. Published in the Annals of Internal Medicine,  highlights the limitations of traditional blood cultures once antibiotics are administered.

AI Info DD req'd. 
Key Publications  Dr. McCurdy has authored over 100 peer-reviewed manuscripts. The following are the most relevant studies and papers regarding sepsis diagnostics and his work with Clairyon: 
 
Sepsis Alliance Collaborative Statement (2025): "Challenges Facing Developers of Diagnostic Tests for Sepsis: A Report From Sepsis Alliance and the Infection Management and Sepsis Collaborative Community. 
"Role: Michael T. McCurdy is the lead author. 
 
This paper evaluates the regulatory and clinical hurdles for diagnostic tests like T2MR, host-based assays, and other rapid pathogen identification tools.  
 
Diagnostic Sensitivity Study (2019): "Blood Culture Results Before and After Antimicrobial Administration in Patients With Severe Manifestations of Sepsis: A Diagnostic Study. Published in the Annals of Internal Medicine,  highlights the limitations of traditional blood cultures once antibiotics are administered.